Immunotherapy
The second edition of Immunotherapy is an updated overview of immuno-oncology in acute myleloid leukemia, non-small cell lung cancer and melanoma, showcasing advances in the management of cancer broadly classified as hematological malignancies and solid tumors. Though the spectrum of clinical activi...
| Corporate Author: | |
|---|---|
| Other Authors: | , |
| Language: | English |
| Published: |
Cham :
Springer International Publishing : Imprint: Springer,
2018.
|
| Edition: | 2nd ed. 2018. |
| Series: | Advances in Experimental Medicine and Biology,
995 |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/978-3-030-02505-2 |
Table of Contents:
- Overview of Basic Immunology and Translational Relevance for Clinical Investigators
- Immunotherapy for Melanoma
- Immunotherapy in Lung Cancer: A New Age in cancer treatment
- Update on Immunotherapy in AML and MDS: Monoclonal Antibodies and Checkpoint Inhibitors Paving the Road for Clinical Practice
- Skin Reactions to Immune Checkpoint Inhibitors
- Immune-related Adverse Events: Pneumonitis
- Immune checkpoint inhibitors-induced colitis
- Immune checkpoint inhibitors-induced hepatitis
- Symptoms as patient-reported outcomes in cancer patients undergoing immunotherapies .